Riskpilot← Back to searchSign inGet full accessCytomed Oy
OYActiveY-tunnus 2301057-8Laastitie 1Manufacture of basic pharmaceutical products · NACE 2110Est. 20091 employees
Revenue 2024
EUR 3,7M
-4% vs 2023
EBITDA margin
8.5%
+126% vs 2023
Equity ratio
74.1%
Financial strength
Net profit 2024
EUR -174K
+59% vs 2023
| Revenue | EUR 3,7M | -4% |
| EBITDA | EUR 310K | +126% |
| Net profit | EUR -174K | +59% |
| Total assets | EUR 8,4M | -2% |
| Equity | EUR 6,2M | -3% |
| Employees | 1 | — |
Legal name
Cytomed Oy
Y-tunnus number
2301057-8
Legal form
Osakeyhtiö
NACE code
2110 · Manufacture of basic pharmaceutical products
Founded
25. marraskuuta 2009
Share capital
EUR 3 050
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on lääkkeiden ja lääkevalmisteiden tutkimus ja kehitys, valmistaminen, osto ja myynti sekä tuonti ja vienti siinä laajuudessa kuin yhtiölle on myönnetty toimintaan voimassa olevan lainsäädännön mukaiset luvat.
Address
Laastitie 1
Phone
+358056681101
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 469 | 4 114 | 2 811 | 3 816 | 3 663 |
| Staff expenses | −1 535 | −1 505 | −1 537 | −1 486 | −1 521 |
| EBITDA | −801 | 602 | −734 | 137 | 310 |
| Depreciation & amort. | −691 | −768 | −654 | −557 | −484 |
| EBIT | −1 493 | −166 | −1 388 | −420 | −174 |
| Net financials | −0 | −0 | −0 | −1 | −0 |
| Profit before tax | −1 493 | −166 | −1 388 | −421 | −174 |
| Tax | −1 | −0 | −0 | −0 | −0 |
| Net profit | −1 491 | −166 | −1 388 | −421 | −174 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 10 209 | 9 362 | 8 462 | 8 636 | 8 426 |
| Equity | 8 390 | 8 224 | 6 835 | 6 414 | 6 240 |
| Long-term debt | 1 241 | 400 | 916 | 1 424 | 1 427 |
| Short-term debt | 579 | 738 | 711 | 797 | 759 |
| Total debt | 1 819 | 1 138 | 1 627 | 2 221 | 2 186 |
EBITDA margin
8.5%
This company
15.8%
Market median
-46% vs market
20202024
Equity ratio
74.1%
This company
38.2%
Market median
+94% vs market
20202024
Return on equity
-2.8%
This company
18.4%
Market median
-115% vs market
20202024
Net profit margin
-4.7%
This company
8.1%
Market median
-158% vs market
20202024
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
20202024
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
AN Chief Executive Officer | Chief Executive Officer | 2022 |
OJ Deputy auditor | Deputy auditor | 2023 |
PJ Audit | Audit | 2023 |
| Former (1) | ||
YW Chief Executive Officer | Chief Executive Officer | 2012 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairperson | 2012 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cytomed Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Nevvonen | Chief Executive Officer | 0 companies |
| Olli Juhani Muukkonen | Deputy auditor | 0 companies |
| Yulia Wolkoff | Chief Executive Officer | 0 companies |
| Pasi Juhani Waris | Audit | 0 companies |
| Alexander Pushkarev | Board of Directors | 0 companies |
| Alexey Chernyshev | Board of Directors | 0 companies |
| Alexander Khromov | Chairperson | 0 companies |
| Vladislav Chernyshev | Board of Directors | 0 companies |